Delivery Order SPE2DB22D1041-SPE2DB24FTZJ2
Award Date 1/22/24
Potential Completion Date 1/23/24
Potential Value $6.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,335.47 firm fixed-price delivery order is for the supply of Pioglitazone HCL 30 mg tablets. The contract has an ultimate completion date of June 18, 2025. Amerisourcebergen Drug Corp also holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,669.15, is a Firm Fixed Price Delivery Order for the supply of Pioglitazone HCL 45 MG Tablets. The contract has an ultimate completion date of February 7, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which...
- This federal contract award, with ID SPE2DB20D3103|SPE2DB24FN3V4, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distribution company. The $6,395.86 contract is for the delivery of 4,564,234,410 units of pioglitazone HCL 45 mg tablets. The contract has a firm fixed-price pricing type and runs through April 11, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is also registered in the System for Award...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,899.44 firm-fixed-price delivery order is for the supply of 500 tablets of 30 mg Pioglitazone HCl, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of November 12, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order worth $4,718.88 and involves the delivery of Pioglitazone HCL 15 mg tablets. The contract is a Firm Fixed Price arrangement with a completion date of July 17, 2025. Amerisourcebergen Drug Corp is a for-profit organization registered in the System for Award Management (SAM.gov) and serves...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $3,375.08, is for the delivery of pioglitazone HCL 30 mg tablets, a medication used to treat type 2 diabetes. The contract is a Firm Fixed Price Delivery Order with a period of performance through December 20, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
- This federal contract award with ID SPE2DB20D3103 and SPE2DB24FM6R4 was made by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $1,720.29, is a Firm Fixed Price Delivery Order for the supply of 4563651894 - Pioglitazone HCL 45 MG Tablets. The contract has an ultimate completion date of February 14, 2024 and was awarded on February 13, 2024. The place of performance is Conshohocken, PA. This award is associated with a larger...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $1,136.43 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Pioglitazone HCL 45 mg tablets. This order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The $2,164.64 firm fixed-price delivery order is for the supply of 90-count tablets of the diabetes medication Pioglitazone Hydrochloride 45 milligrams. The contract has a period of performance through June 30, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,847.10 for Pioglitazone HCL 45 mg tablets (90-count) on September 23, 2025, with a completion date of September 24, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The award represents a continuation of pharmaceutical supply fulfillment under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical, a comprehensive $1...